Press Releases Select Year 2025 2024 2023 2022 2021 Mar 18, 2025 Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly's Injectable Zepbound® Feb 27, 2025 The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience Feb 24, 2025 Ethics Board Approval Received for DehydraTECH-tirzepatide GLP-1 Study-Arm Feb 20, 2025 Lexaria's Strategic Business Pursuit of DehydraTECH-Liraglutide Feb 11, 2025 Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy First | Previous | Next | Last
